IDENTIFICATION OF 2 MAJOR BILIARY METABOLITES OF CARVEDILOL IN RATS

被引:19
作者
FUJIMAKI, M
HAKUSUI, H
机构
[1] Drug Metabolism and Analytical Chemistry Research Center, Research Institute, Daiichi Pharmaceutical Co. Ltd, Edogawa-ku, Tokyo, 134, 1-16-13, Kitakasai
关键词
D O I
10.3109/00498259009046823
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. After separate administration of R(+)-carvedilol, S(-)-carvedilol and (±14C-carvedilol to rats at an oral dose of 10mg/kg, the metabolic pattern in the bile was studied using h.p.l.c. with radioactivity and u.v. monitoring. 2. Two major metabolites, M-1 and M-2, present in the bile, accounted for 39% and 22% dose, respectively. 3. M-1 and M-2 were characterized as 1-hydroxycarvedilol O-glucuronide and 8-hydroxycarvedilol O-glucuronide, respectively, from FAB-mass spectrometry, 1H-n.m.r. and enzymic hydrolysis. 4. Oral administration of R(+)-carvedilol led to highly selective excretion of M-1 in bile whereas S(-)-carvedilol resulted predominantly in excretion of M-2 rather than M-1. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:1025 / 1034
页数:10
相关论文
共 7 条
[1]  
FUJIMAKI M, 1989, XENOBIOTIC METAB DIS, V4, P667
[2]  
FUJIMAKI M, 1989, XENOBIOTIC METABOLIS, V4, P693
[3]  
HAKUSUI H, 1989, XENOBIO METABOL DISP, V4, P637
[4]  
NEUBERT P, 1986, METABOLISM CARVEDILO
[5]  
NEUGEBAUER G, 1987, Journal of Cardiovascular Pharmacology, V10, pS85
[6]  
SCHMIDT H, 1987, HIGH PRESSURE LIQUID
[7]   PHARMACOLOGICAL PROFILE OF CARVEDILOL AS A BETA-BLOCKING AGENT WITH VASODILATING AND HYPOTENSIVE PROPERTIES [J].
SPONER, G ;
BARTSCH, W ;
STREIN, K ;
MULLERBECKMANN, B ;
BOHM, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 9 (03) :317-327